IAIM
APTO

International Assets Investment Management’s Aptose Biosciences, Inc. APTO Stock Holding History

International Assets Investment Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33
Closed -$8.7K – 1394
2022
Q4 		$8.7K Buy
+33
New +$8.86K ﹤0.01% 792

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $733M AUM 11.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

International Assets Investment Management's APTO Position: Q1 2023 in Review

International Assets Investment Management sold out of Aptose Biosciences, Inc. (APTO) in Q1 2023, closing a stake of 33 shares — an estimated $8.7K sold.

International Assets Investment Management first reported a position in APTO in Q4 2022 and held it in 1 quarter. The position peaked at $8.7K in Q4 2022. 44 funds tracked by Wall St. Rank hold APTO as of Q1 2023.

  • International Assets Investment Management reported no remaining Aptose Biosciences, Inc. position as of Q1 2023 after selling out during the quarter.
  • International Assets Investment Management sold 33 Aptose Biosciences, Inc. shares in Q1 2023, an estimated $8.7K.
  • International Assets Investment Management first reported a position in Aptose Biosciences, Inc. in Q4 2022 and held it in 1 quarter.
  • International Assets Investment Management's Aptose Biosciences, Inc. position peaked at $8.7K in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2023.

Based on International Assets Investment Management's 13F filing for Q1 2023, filed 19 Apr 2023.